Hepatocyte nuclear factor 1-alpha (HNF-1α) is a transcription factor that plays a crucial role in liver development and function. Dysregulation of HNF-1α is linked to type 2 diabetes and other metabolic disorders. HNF-1α Activators pertain to a group of compounds designed to modulate the activity of Hepatocyte Nuclear Factor 1-alpha (HNF-1α), a transcription factor that plays a pivotal role in regulating gene expression in various tissues, particularly in the liver, pancreas, and kidney. HNF-1α is a member of the homeodomain-containing protein family and is critical for maintaining tissue-specific functions, such as glucose homeostasis and lipid metabolism. The activators within this chemical class likely interact with HNF-1α, influencing its DNA-binding ability and transcriptional activity.
In molecular biology, transcription factors like HNF-1α are responsible for controlling the expression of specific genes by binding to their promoter regions. These factors serve as molecular switches that can turn genes on or off, and their precise regulation is essential for normal cellular function. HNF-1α, in particular, is associated with the regulation of genes involved in glucose metabolism and insulin production in the pancreas, making it a key player in diabetes-related research. HNF-1α activators, therefore, are valuable tools for researchers aiming to study the intricate mechanisms underlying these processes. They can be used to manipulate HNF-1α activity in experimental settings, allowing scientists to better understand the role of this transcription factor in health and disease. Additionally, such activators may find applications in developing novel research techniques and assays to uncover the broader implications of HNF-1α-mediated gene regulation in various tissues and physiological contexts.
SEE ALSO...
Items 1 to 10 of 12 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Nicotinamide | 98-92-0 | sc-208096 sc-208096A sc-208096B sc-208096C | 100 g 250 g 1 kg 5 kg | $44.00 $66.00 $204.00 $831.00 | 6 | |
Inhibits SIRT1 deacetylase, increasing HNF-1α acetylation and transcriptional activity. | ||||||
Troglitazone | 97322-87-7 | sc-200904 sc-200904B sc-200904A | 5 mg 10 mg 25 mg | $110.00 $204.00 $435.00 | 9 | |
PPARγ agonist that binds PPRE in HNF-1α promoter and increases its transcription. | ||||||
Fenofibrate | 49562-28-9 | sc-204751 | 5 g | $41.00 | 9 | |
PPARα agonist that activates PPAR response element in HNF-1α promoter region. | ||||||
(−)-Epigallocatechin Gallate | 989-51-5 | sc-200802 sc-200802A sc-200802B sc-200802C sc-200802D sc-200802E | 10 mg 50 mg 100 mg 500 mg 1 g 10 g | $43.00 $73.00 $126.00 $243.00 $530.00 $1259.00 | 11 | |
Antioxidant that decreases HNF-1α promoter methylation via effects on DNMT1. | ||||||
Deferoxamine mesylate | 138-14-7 | sc-203331 sc-203331A sc-203331B sc-203331C sc-203331D | 1 g 5 g 10 g 50 g 100 g | $255.00 $1060.00 $2923.00 $4392.00 $8333.00 | 19 | |
Chelate of iron that reduces oxidative degradation of HNF-1α. | ||||||
Resveratrol | 501-36-0 | sc-200808 sc-200808A sc-200808B | 100 mg 500 mg 5 g | $80.00 $220.00 $460.00 | 64 | |
SIRT1 activator that may indirectly increase HNF-1α transcriptional activity. | ||||||
MG-132 [Z-Leu- Leu-Leu-CHO] | 133407-82-6 | sc-201270 sc-201270A sc-201270B | 5 mg 25 mg 100 mg | $60.00 $265.00 $1000.00 | 163 | |
Proteasome inhibitor preventing ubiquitin-mediated degradation of HNF-1α. | ||||||
SB 431542 | 301836-41-9 | sc-204265 sc-204265A sc-204265B | 1 mg 10 mg 25 mg | $82.00 $216.00 $416.00 | 48 | |
TGF-β inhibitor that prevents transcriptional repression of HNF-1α. | ||||||
Losartan Potassium | 124750-99-8 | sc-204796 sc-204796B sc-204796C sc-204796A | 1 g 25 g 100 g 5 g | $54.00 $385.00 $1051.00 $126.00 | 10 | |
AT1 receptor antagonist that decreases angiotensin effects on HNF-1α. | ||||||
Benfotiamine | 22457-89-2 | sc-204639 sc-204639A | 250 mg 1 g | $52.00 $171.00 | ||
Activates PKC pathways enhancing HNF-1α phosphorylation/activity. | ||||||